BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Applied StemCell, Inc. Enters Strategic Partnership With Charles River Laboratories (Massachusetts)


3/19/2013 2:47:42 PM

Menlo Park, CA–Mar. 14, 2013—Applied StemCell, Inc. (ASC) announced today it has signed a strategic agreement with Charles River Laboratories International, Inc. (NYSE: CRL) for the distribution of ASC’s genetically modified TARGATT™ mouse. With this agreement, Charles River becomes the worldwide distributor of the TARGATT™ (FVB) mouse. ASC’s IP based technology, TARGATT™ allows a gene of interest to be stably integrated into a well-characterized, transcriptionally-active locus in the mouse genome with guaranteed transgene expression. With the TARGATT™ (FVB) mouse and transgenic kit (available from ASC), researchers are able to generate a site-specific knock-in mouse in as lfast as 3 months.

Ruhong Jiang, President and CEO of Applied StemCell, Inc. said, “We are extremely pleased that ASC and Charles River have entered into a strategic partnership. This expands our accessibility to the research market and builds a new platform to deliver innovative gene modification solutions. We will continuously work together to seek new business opportunities.”

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerating their research and drug development efforts. (www.criver.com)

Applied StemCell, Inc. is a leading provider in stem cell products and services including MEF Feeder Cells, Transgenic Knock-in Mice, Knock-out Rats, Teratoma Formation Services, Human Primary Cells, Stem Cell Characterization, Stem Cell Differentiation and Stem Cell Generation. We strive to improve while expanding our technologies and product lines to meet the increasing requirements of biomedical community. Applied StemCell always welcomes your comments, suggestions and ideas.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->